×
About 78,310 results

ALLMedicine™ Hepatitis B Center

Research & Reviews  37,551 results

Characterization and Application of Precore/Core-Related Antigens in Animal Models of H...
https://doi.org/10.1002/hep.31720
Hepatology (Baltimore, Md.); Hong X, Luckenbaugh L et. al.

Jan 18th, 2021 - The hepatitis B core-related antigen (HBcrAg), a composite antigen of precore/core gene including classical hepatitis B core antigen (HBc) and e antigen (HBeAg), and additionally, the precore-related antigen PreC, retaining the N-terminal signal p...

Trends and strategies to combat viral infections: A review on FDA approved antiviral dr...
https://doi.org/10.1016/j.ijbiomac.2021.01.076
International Journal of Biological Macromolecules; Tompa DR, Immanuel A et. al.

Jan 17th, 2021 - The infectious microscopic viruses invade living cells to reproduce themselves, and causes chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to death if not treated. Different strategies have been utilized ...

Durability of Hepatitis B Surface Antigen seroclearance and subsequent Risk for hepatoc...
https://doi.org/10.1111/jvh.13471
Journal of Viral Hepatitis; Song A, Xiaoxiao W et. al.

Jan 17th, 2021 - Hepatitis B surface antigen (HBsAg) seroclearance is regarded as the ideal endpoint for antiviral treatment. However, reports on the durability of and outcomes after HBsAg seroclearance are few, which has become a focus in clinical practice. This ...

Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine i...
https://doi.org/10.1016/j.vaccine.2020.12.050
Vaccine Atsmon J, Machluf N et. al.

Jan 16th, 2021 - Sci-B-Vac® is a tri-antigenic recombinant Hepatitis B vaccine (TAV) containing the small (s), medium (pre-S2) and large (pre-S1) hepatitis B surface (HBs) antigens. To comply with vaccine licensure, a new reference standard batch was qualified by ...

Impact of maternal infection with hepatitis B virus on pregnancy complications and neon...
https://doi.org/10.1111/jvh.13472
Journal of Viral Hepatitis; Xiong Y, Liu C et. al.

Jan 16th, 2021 - To investigate the impact of maternal hepatitis B virus (HBV) status on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology (ART). A total of 7,011 pregnancies achieved by ART were included from a po...

see more →

Guidelines  135 results

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP

Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL

Feb 6th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...

Management of hepatitis B virus infection, updated Swedish guidelines.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.

Oct 15th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Screening for Hepatitis B Virus Infection in Pregnant Women US Preventive Services Task Force Reaffirmation Recommendation Statement
https://jamanetwork.com/journals/jama/fullarticle/2738558
JAMA

Jul 22nd, 2019 - Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100...

Hepatitis B Screening in Pregnant Women A Perspective on the New USPSTF Recommendations
https://jamanetwork.com/journals/jama/fullarticle/2738527
JAMA

Jul 22nd, 2019 - Contemporary clinicians who provide obstetric care acknowledge screening of pregnant women for perinatally transmissible infectious diseases as a routine component of prenatal care,1 although this has not always been the case. For example, prenata...

see more →

Drugs  243 results see all →

Clinicaltrials.gov  38,861 results

Characterization and Application of Precore/Core-Related Antigens in Animal Models of H...
https://doi.org/10.1002/hep.31720
Hepatology (Baltimore, Md.); Hong X, Luckenbaugh L et. al.

Jan 18th, 2021 - The hepatitis B core-related antigen (HBcrAg), a composite antigen of precore/core gene including classical hepatitis B core antigen (HBc) and e antigen (HBeAg), and additionally, the precore-related antigen PreC, retaining the N-terminal signal p...

Trends and strategies to combat viral infections: A review on FDA approved antiviral dr...
https://doi.org/10.1016/j.ijbiomac.2021.01.076
International Journal of Biological Macromolecules; Tompa DR, Immanuel A et. al.

Jan 17th, 2021 - The infectious microscopic viruses invade living cells to reproduce themselves, and causes chronic infections such as HIV/AIDS, hepatitis B and C, flu, etc. in humans which may lead to death if not treated. Different strategies have been utilized ...

Durability of Hepatitis B Surface Antigen seroclearance and subsequent Risk for hepatoc...
https://doi.org/10.1111/jvh.13471
Journal of Viral Hepatitis; Song A, Xiaoxiao W et. al.

Jan 17th, 2021 - Hepatitis B surface antigen (HBsAg) seroclearance is regarded as the ideal endpoint for antiviral treatment. However, reports on the durability of and outcomes after HBsAg seroclearance are few, which has become a focus in clinical practice. This ...

Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine i...
https://doi.org/10.1016/j.vaccine.2020.12.050
Vaccine Atsmon J, Machluf N et. al.

Jan 16th, 2021 - Sci-B-Vac® is a tri-antigenic recombinant Hepatitis B vaccine (TAV) containing the small (s), medium (pre-S2) and large (pre-S1) hepatitis B surface (HBs) antigens. To comply with vaccine licensure, a new reference standard batch was qualified by ...

Impact of maternal infection with hepatitis B virus on pregnancy complications and neon...
https://doi.org/10.1111/jvh.13472
Journal of Viral Hepatitis; Xiong Y, Liu C et. al.

Jan 16th, 2021 - To investigate the impact of maternal hepatitis B virus (HBV) status on pregnancy complications and neonatal outcomes for women undergoing assisted reproductive technology (ART). A total of 7,011 pregnancies achieved by ART were included from a po...

see more →

News  1,485 results

Eliminating Hepatitis by 2030: HHS Releases New Strategic Plan
https://www.medscape.com/viewarticle/944180

Jan 14th, 2021 - In an effort to counteract alarming trends in rising hepatitis infections, the U.S. Department of Health and Human Services has developed and released its Viral Hepatitis National Strategic Plan 2021-2025, which aims to eliminate viral hepatitis i...

USPSTF Reaffirms Advice on HBV Screening in High-Risk Individuals
https://www.medscape.com/viewarticle/942681

Dec 15th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...

Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment
https://www.medscape.com/viewarticle/941160

Nov 19th, 2020 - In celebration of Medscape's 25th birthday, we are highlighting key breakthroughs that have defined the last quarter century of medicine, as chosen by experts in their respective fields. Over the past 25 years, cirrhosis and its related complicati...

Aspirin and Statins in Chronic Hepatitis B: It's Complicated
https://www.staging.medscape.com/viewarticle/941289

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...

Aspirin and Statins in Chronic Hepatitis B: It's Complicated
https://www.medscape.com/viewarticle/941289

Nov 18th, 2020 - For patients with chronic hepatitis B, the protective effects of aspirin against hepatocellular carcinoma (HCC) can vary with cirrhosis status and statin treatment, a pair of new studies finds. One study showed that although aspirin is linked to a...

see more →

Patient Education  35 results see all →